Prognomiq Inc. reported the launch of its Provue Lung, a novel blood-based laboratory developed test designed to help improve detection of lung cancer at its earliest, most treatable stages.
NEW YORK – A pair of diagnostics firms issued news this week pushing forward their efforts to enter the lung cancer early detection space. San Mateo, California-based PrognomiQ announced Tuesday the ...
SAN MATEO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- PrognomiQ, a healthcare company focused on harnessing the power of proteomics and multi-omics data to transform the detection and early treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results